Abstract
AbstractSummary:13C solid‐state NMR and 1H relaxation time measurements have been used to determine the structure of the crystalline and amorphous forms of the pharmaceutical drug indomethacin. Cross‐polarization dynamics parameters were calculated for individual NMR resonances providing an insight into the mobility of functional groups in two forms of indomethacin. The changes of mobility in indomethacin/polyvinylpyrrolidone (PVP) formulation have been investigated via1H‐13C solid‐state NMR methods.Differences between the amorphous material and its crystalline counterpart have been observed. The γ‐amorphous indomethacin rapidly crystallizes with time. It has been shown that encapsulation in the PVP stabilizes the amorphous form of the drug by preventing crystallization due to reduced mobility of the guest in the formulation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
